<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-vaccines-07-00091">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McKee</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>V.L.</given-names>
   </name>
   <name>
    <surname>Clow</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Hayman</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Baird</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Hermans</surname>
    <given-names>I.F.</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Ward</surname>
    <given-names>V.K.</given-names>
   </name>
  </person-group>
  <article-title>Virus-like particles and alpha-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses</article-title>
  <source>J. Control. Release Off. J. Control. Release Soc.</source>
  <year>2012</year>
  <volume>159</volume>
  <fpage>338</fpage>
  <lpage>345</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jconrel.2012.02.015</pub-id>
 </element-citation>
</ref>
